OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
QLMI$2.2459

QLM Life & Medical Insurance Company QPSC

Life & Health InsuranceVerified

QLM Life & Medical Insurance Company QPSC maintains a strong liquidity position, with cash and equivalents amounting to QAR 535.4 million, representing 30% of its total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, supported by a free cash flow of QAR 31.0 million and a debt-to-equity ratio of 0.24, indicating a conservative capital structure. The price-to-book ratio of 1.11 suggests the company is trading at a slight premium to its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets. In terms of profitability, QLM reported a net income of QAR 65.5 million and an operating income of QAR 78.9 million in the latest period. The return on equity (ROE) of 9.29% and return on assets (ROA) of 3.66% are in line with industry norms for life and health insurers, which typically exhibit moderate ROE due to the long-term nature of their liabilities. The company's price-to-earnings ratio of 11.97 is slightly below the industry median, suggesting it may be undervalued relative to its earnings. QLM's revenue is concentrated in the Kingdom of Qatar, as it is a Qatari domestic insurer with no disclosed international operations. The company operates in a single business segment, focusing on life and health insurance products, and does not report revenue by geographic region or product line. This concentration may expose the company to regulatory and economic risks specific to Qatar, though it also allows for focused operational efficiency. The company's growth trajectory is modest, with no significant revenue growth reported in the latest financials. Analysts have assigned a mean price target of QAR 2.37, which is only 6.5% above the current market price of QAR 2.24. This suggests limited upside potential in the near term, though the company's strong liquidity and conservative leverage position it well for long-term stability. QLM's risk profile is low, with no immediate liquidity or dilution flags detected in its filings. The company has not issued new shares in the recent period, and its diluted share count is equal to its basic share count, indicating no dilution pressure. The absence of significant debt and the presence of substantial cash reserves further reduce financial risk. Recent filings and transcripts do not indicate any material events or strategic shifts for QLM in the past quarter. The company continues to operate within its core insurance business, with no disclosed expansion plans or major investments. Analysts have issued one "buy" recommendation and no "strong buy" or "hold" ratings, suggesting a cautious but positive outlook.

30-day price · QLMI+0.00 (+0.2%)
Low$2.05High$2.45Close$2.31As of21 May, 00:00 UTC
Profile
CompanyQLM Life & Medical Insurance Company QPSC
TickerQLMI.QA
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. QLM Life & Medical Insurance Company QPSC provides life and health insurance services in the Kingdom of Qatar, generating revenue primarily through premium income and investment returns on its insurance reserves.

Classification. QLM is classified under the Life & Health Insurance industry within the Financials sector, with a high confidence level of 0.92 based on verified market data.

QLM Life & Medical Insurance Company QPSC maintains a strong liquidity position, with cash and equivalents amounting to QAR 535.4 million, representing 30% of its total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, supported by a free cash flow of QAR 31.0 million and a debt-to-equity ratio of 0.24, indicating a conservative capital structure. The price-to-book ratio of 1.11 suggests the company is trading at a slight premium to its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets. In terms of profitability, QLM reported a net income of QAR 65.5 million and an operating income of QAR 78.9 million in the latest period. The return on equity (ROE) of 9.29% and return on assets (ROA) of 3.66% are in line with industry norms for life and health insurers, which typically exhibit moderate ROE due to the long-term nature of their liabilities. The company's price-to-earnings ratio of 11.97 is slightly below the industry median, suggesting it may be undervalued relative to its earnings. QLM's revenue is concentrated in the Kingdom of Qatar, as it is a Qatari domestic insurer with no disclosed international operations. The company operates in a single business segment, focusing on life and health insurance products, and does not report revenue by geographic region or product line. This concentration may expose the company to regulatory and economic risks specific to Qatar, though it also allows for focused operational efficiency. The company's growth trajectory is modest, with no significant revenue growth reported in the latest financials. Analysts have assigned a mean price target of QAR 2.37, which is only 6.5% above the current market price of QAR 2.24. This suggests limited upside potential in the near term, though the company's strong liquidity and conservative leverage position it well for long-term stability. QLM's risk profile is low, with no immediate liquidity or dilution flags detected in its filings. The company has not issued new shares in the recent period, and its diluted share count is equal to its basic share count, indicating no dilution pressure. The absence of significant debt and the presence of substantial cash reserves further reduce financial risk. Recent filings and transcripts do not indicate any material events or strategic shifts for QLM in the past quarter. The company continues to operate within its core insurance business, with no disclosed expansion plans or major investments. Analysts have issued one "buy" recommendation and no "strong buy" or "hold" ratings, suggesting a cautious but positive outlook.
Key takeaways
  • QLM maintains a conservative capital structure with a low debt-to-equity ratio of 0.24 and strong liquidity.
  • The company's ROE of 9.29% is in line with industry norms, but its P/E ratio of 11.97 suggests it may be undervalued.
  • QLM's operations are concentrated in Qatar, with no international diversification or segment reporting.
  • Analysts have assigned a modest price target of QAR 2.37, indicating limited near-term upside.
  • The company has no immediate liquidity or dilution risks, with no new share issuance in the latest period.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyQAR
Revenue
Gross profit
Operating income$78.9M
Net income$65.5M
R&D
SG&A
D&A
SBC
Operating cash flow$19.3M
CapEx-$934.0k
Free cash flow$31.0M
Total assets$1.79B
Total liabilities$1.08B
Total equity$705.6M
Cash & equivalents$535.4M
Long-term debt$166.0M
Valuation
Market price$2.24
Market cap$784.4M
Enterprise value$414.9M
P/E12.0
Reported non-GAAP P/E
EV/Revenue
EV/Op income5.3
EV/OCF21.5
P/B1.1
P/Tangible book1.1
Tangible book$705.6M
Net cash$369.4M
Current ratio
Debt/Equity0.2
ROA3.7%
ROE9.3%
Cash conversion29.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricQLMIActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity24.0%27.5% medp25 4.7% · p75 66.5%below median
Observations
IR observations
Mean price target2.37 QAR
Median price target2.37 QAR
High price target2.37 QAR
Low price target2.37 QAR
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.21 QAR
Last actual EPS0.19 QAR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 12:50 UTC#913bebaa
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 03:06 UTCJob: a6c1aeca